Streamlined MDI Development Partnership

Written By PY

Discover the pioneering collaboration between OzUK and Ab Initio Pharma that seamlessly advances the development and GMP manufacturing of metered dose inhalers (MDIs) from initial research through to commercialisation.

PY
Previous

Clinical Trial Support Services: Focus on GMP
Next

Revolutionising Nasal Product Development and Manufacturing